NCT06776328 Co-creation of Tools for Children and Adolescents with Suicidal Thoughts And/or Behaviour
| NCT ID | NCT06776328 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Ghent |
| Condition | Suicide Prevention |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-12-12 |
| Primary Completion | 2026-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-12-12 with a primary completion date of 2026-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Evidence shows that there are very few evidence-based tools or interventions specifically targeting suicidality in children and adolescents. It is crucial to address suicidal thoughts in these populations, as research indicates that discussing suicidality does not increase suicidal behavior but may instead reduce the associated risk. Furthermore, the field of suicide prevention increasingly incorporates digital technologies. Studies suggest that digital interventions targeting suicidality in young people show promise in enhancing knowledge, regulating emotions, developing coping skills, and managing suicidal thoughts and behaviors. As part of this project, we will develop the following practical tools: * A creative methodology for professionals to engage children and adolescents in talking about their suicidal thoughts. * A self-help app for suicidal young people and their support networks. The development process will involve co-creation, with input from children and adolescents playing a central role. A total of 30 children and adolescents aged 10 to 18 years, who have experienced suicidal thoughts in the past, will participate in this project. The co-creation sessions will be conducted in groups of up to 10 participants. Participants can attend a minimum of 1 and a maximum of 10 sessions, each lasting up to 1.5 hours. The sessions will be facilitated by researchers from VLESP and will take place at a location convenient for participants or in Ghent (the primary location of the research team). If preferred by participants, one or more sessions may also be held online. For participants who do not wish to join a group, individual sessions can be arranged. Each session will be attended by two researchers, with the potential involvement of professionals specializing in tool development. Several potential developers will be invited to submit proposals for creating the tools, and the selection of the developer will be based on these submissions. During the sessions, participants will review and evaluate various prototypes of the app. However, the prototypes will not be tested for effectiveness by the young participants.
Eligibility Criteria
Inclusion Criteria: * Aged 10-18 years * Proficient in Dutch * Has experienced suicidal thoughts in the past Exclusion Criteria (as assessed by the care provider): * Limited cognitive ability * Currently experiencing an acute suicidal crisis
Contact & Investigator
Gwendolyn Portzky, PhD
PRINCIPAL INVESTIGATOR
Flemish Centre of Expertise in Suicide Prevention, Department of Head and Skin, UGent
Frequently Asked Questions
Who can join the NCT06776328 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 18 Years, studying Suicide Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06776328 currently recruiting?
Yes, NCT06776328 is actively recruiting participants. Contact the research team at eva.dejaegere@ugent.be for enrollment information.
Where is the NCT06776328 trial being conducted?
This trial is being conducted at Ghent, Belgium.
Who is sponsoring the NCT06776328 clinical trial?
NCT06776328 is sponsored by University Ghent. The principal investigator is Gwendolyn Portzky, PhD at Flemish Centre of Expertise in Suicide Prevention, Department of Head and Skin, UGent. The trial plans to enroll 30 participants.